Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1948 1
1949 1
1950 1
1951 1
1952 1
1953 1
1954 1
1956 1
1957 5
1958 4
1959 1
1960 4
1961 3
1962 2
1963 1
1964 5
1965 4
1966 2
1967 5
1968 8
1969 5
1970 3
1971 18
1972 6
1973 3
1974 9
1975 10
1976 5
1977 8
1978 6
1979 6
1980 19
1981 18
1982 37
1983 14
1984 12
1985 16
1986 13
1987 14
1988 9
1989 8
1990 16
1991 21
1992 18
1993 18
1994 24
1995 18
1996 17
1997 21
1998 23
1999 20
2000 31
2001 25
2002 27
2003 26
2004 36
2005 51
2006 53
2007 50
2008 59
2009 55
2010 64
2011 58
2012 66
2013 68
2014 67
2015 44
2016 55
2017 73
2018 54
2019 47
2020 68
2021 73
2022 81
2023 19
Text availability
Article attribute
Article type
Publication date

Search Results

1,601 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group. de Boer SM, et al. Among authors: baron mh. Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Lancet Oncol. 2018. PMID: 29449189 Free PMC article. Clinical Trial.
Notch3 in Development, Health and Disease.
Hosseini-Alghaderi S, Baron M. Hosseini-Alghaderi S, et al. Among authors: baron m. Biomolecules. 2020 Mar 23;10(3):485. doi: 10.3390/biom10030485. Biomolecules. 2020. PMID: 32210034 Free PMC article. Review.
Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.
Campbell NR, Rao A, Hunter MV, Sznurkowska MK, Briker L, Zhang M, Baron M, Heilmann S, Deforet M, Kenny C, Ferretti LP, Huang TH, Perlee S, Garg M, Nsengimana J, Saini M, Montal E, Tagore M, Newton-Bishop J, Middleton MR, Corrie P, Adams DJ, Rabbie R, Aceto N, Levesque MP, Cornell RA, Yanai I, Xavier JB, White RM. Campbell NR, et al. Among authors: baron m. Dev Cell. 2021 Oct 25;56(20):2808-2825.e10. doi: 10.1016/j.devcel.2021.08.018. Epub 2021 Sep 15. Dev Cell. 2021. PMID: 34529939 Free PMC article.
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Müller-Ladner U, Lafyatis R, Stifano G, Spotswood H, Chen-Harris H, Dziadek S, Morimoto A, Sornasse T, Siegel J, Furst DE. Khanna D, et al. Among authors: baron m. Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5. Lancet. 2016. PMID: 27156934 Free article. Clinical Trial.
1,601 results